Filing Details

Accession Number:
0001104659-19-023694
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-25 16:15:27
Reporting Period:
2019-04-23
Accepted Time:
2019-04-25 16:15:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1760542 Hookipa Pharma Inc. HOOK () XX
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441261 Fcpr Vi Capital Sofinnova C/O Hookipa Pharma Inc.
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York NY 10118
No No Yes No
1574139 Sas Partners Sofinnova C/O Hookipa Pharma Inc.
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York NY 10118
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-23 916,901 $0.00 999,357 No 4 C Direct
Common Stock Acquisiton 2019-04-23 1,719,189 $0.00 2,718,546 No 4 C Direct
Common Stock Acquisiton 2019-04-23 888,166 $0.00 3,606,712 No 4 C Direct
Common Stock Acquisiton 2019-04-23 357,142 $14.00 3,963,854 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-04-23 916,901 $0.00 916,901 $0.00
Common Stock Series B Preferred Stock Disposition 2019-04-23 1,719,189 $0.00 1,719,189 $0.00
Common Stock Series C Preferred Stock Disposition 2019-04-23 888,166 $0.00 888,166 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The preferred stock automatically converted into the Issuer's common stock on a one-for-one basis at the closing of the Issuer's initial public offering held on April 23, 2019 without payment or further consideration and had no expiration date.
  2. Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.